Dedong Xiang
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Ishak stage 6 fibrosis is more likely to regress than stage 5 in CHB patients undergoing entecavir therapy.
Journal: Frontiers in medicine
Published: December 11, 2025
Synergistic Effect of Biejia-Ruangan on Fibrosis Regression in Patients With Chronic Hepatitis B Treated With Entecavir: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
Journal: The Journal of infectious diseases
Published: December 26, 2019
A Novel Noninvasive Program for Staging Liver Fibrosis in Untreated Patients With Chronic Hepatitis B.
Journal: Clinical and translational gastroenterology
Published: April 30, 2019
Performance of several simple, noninvasive models for assessing significant liver fibrosis in patients with chronic hepatitis B.
Journal: Croatian medical journal
Published: June 20, 2015
Induction of hepatocyte-like cells from mouse embryonic stem cells by lentivirus-mediated constitutive expression of Foxa2/Hnf4a.
Journal: Journal of cellular biochemistry
Published: January 24, 2013
Rotating microgravity-bioreactor cultivation enhances the hepatic differentiation of mouse embryonic stem cells on biodegradable polymer scaffolds.
Journal: Tissue engineering. Part A
Published: June 21, 2012
Human umbilical cord matrix stem cells efficiently rescue acute liver failure through paracrine effects rather than hepatic differentiation.
Journal: Tissue engineering. Part A
Published: April 24, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026